Top ▲
Ligand name | ID | Synonyms | |||||||
A | Back to top | ||||||||
852A | 9025 | ||||||||
A286982 | 6592 | A 286982, A-286982 | |||||||
A438079 | 4118 | A 438079, A-438079 | |||||||
AB928 | 11154 | AB-928 | |||||||
abatacept | 6891 | BMS-188667, CTLA4-IgG4m, Orencia®, RG-1046, RG-2077 | |||||||
ABBV-3373 | 12917 | ADC 122 | |||||||
abediterol | 9326 | LAS-100977 | |||||||
AbGn-168H | 10013 | AbGn-168, neihulizumab | |||||||
abrezekimab | 9806 | CDP7766, UCB-4144, UCB4144, VR-942 | |||||||
abrilumab | 11531 | AMG 181, AMG-181, MEDI-7183, MEDI7183 | |||||||
abrocitinib | 9991 | Cibinqo®, compound 25 [PMID: 29298069], PF-04965842, PF04965842 | |||||||
abscisic acid | 10362 | (+/-)-(cis,trans)-abscisic acid, (+/-)-Abscisic acid, (RS)-Abscisic acid, ABA | |||||||
ABT-737 | 8320 | ABT 737, ABT737, compound 2 [PMID 17256834] | |||||||
AC430 | 9177 | AC-430 | |||||||
acalabrutinib | 8912 | ACP-196, Calquence®, Example 6 [US20140155385 A1] | |||||||
Ac-SDKP | 10060 | goralatide, seraspenide | |||||||
ACT-1014-6470 | 12326 | example 172 [WO2019137927A1], Ic-58 | |||||||
ACT-389949 | 9511 | ||||||||
ACT-660602 | 12207 | ACT660602, compound 9j [PMID: 35947786] | |||||||
ACT-777991 | 12584 | ACT777991, compound 8a [PMID: 36883854] | |||||||
ACTH | 3633 | Acthar®, adrenocorticotropic hormone (1-39), corticotropin | |||||||
acumapimod | 9203 | BCT 197, BCT-197, BCT197, compound A [WO2013139809] | |||||||
adalimumab | 4860 | D2E7, Humira® | |||||||
(-)-adrenaline | 479 | adrenalin, Auvi-Q®, Epipen®, l-adrenaline, L-epinephrine, levoepinephrine | |||||||
adrenomedullin | 683 | AM | |||||||
adriforant | 8985 | PF 3893787, PF-03893787, ZPL-389, ZPL-3893787, ZPL389, ZPL3893787 | |||||||
ADU-S100 | 10192 | dithio-(Rp,Rp)-[cyclic[A(2',5')pA(3',5')p]], MIW815, ML RR-S2 CDA, S100 | |||||||
AF12198 | 4861 | AF 12198, AF-12198 | |||||||
AFM13 | 10067 | AFM 13, AFM-13 | |||||||
agatolimod | 9843 | CpG 7909, CpG7909, PF 3512676, PF-3512676, ProMune, VaxImmune | |||||||
AH10-7 | 9899 | ||||||||
AH6809 | 1896 | AH 6809, AH-6809 | |||||||
AJ2-30 | 13090 | compound 4 [PMID: 38191941] | |||||||
AL-78898A | 9219 | 4(1MeW), POT-4 | |||||||
alcaftadine | 7587 | Lastacaft®, R-89674 | |||||||
alefacept | 6787 | Amevive®, BG 9273, BG 9712, BG-9273, BG-9712, Lfa3Tip | |||||||
alemtuzumab | 6770 | campath 1H, Campath®, campath-1H, Lemtrada® | |||||||
alimemazine | 7237 | Nedeltran®, trimeprazine | |||||||
3 alpha-aminocholestane | 9564 | 3AC, 3 α-aminocholestane | |||||||
ALT-803 | 9615 | IL-15 N72D:IL-15RαSu/Fc, IL-15SA, N-803 | |||||||
alvelestat | 6476 | AZD 9668, AZD-9668, AZD9668, KB-105160 | |||||||
AM-461 | 10170 | AM461, Compound 1 [WO2011085033] | |||||||
AM-6120 | 10119 | AM6120, peptide 41 [PMID: 30346167] | |||||||
amcinonide | 7060 | CL-34699, Cyclocort® | |||||||
amelenodor | 13384 | example 2 [WO2020010132A1], NX-13, NX13 | |||||||
amelubant | 8463 | BIIL 284, BIIL-284 | |||||||
AMG319 | 8917 | AMG 319, AMG-319 | |||||||
AMG487 | 13071 | AMG 487, AMG-487, compound 47 [PMID: 17448658] | |||||||
AMG820 | 9106 | ||||||||
aminopyridine 2 | 10051 | ||||||||
amiselimod | 9319 | Example 1 [US20090137530], MT-1303, MT1303 | |||||||
amiselimod phosphate | 9491 | amiselimod-P, MT-1303-P | |||||||
amlexanox | 7113 | AA-673, Amlexanox®, Aphthasol®, CHX-3673 | |||||||
amphiregulin | 4864 | colorectal cell-derived growth factor (CRDGF) | |||||||
AMT-101 | 11645 | ||||||||
AMY109 | 12789 | AMY-109, H1009/L395-F1974m | |||||||
anakinra | 6972 | antril, Kineret® | |||||||
anatumomab mafenatox | 9947 | 5T4FabV13SEAD227A, ABR 214936, ABR-214936, ABR214936, pMB125, PNU 214936, PNU-214936, PNU214936, TTS-CD2 | |||||||
ancriviroc | 804 | SCH 351125, SCH-351125, SCH-C | |||||||
andecaliximab | 9510 | GS-5745, GS5745 | |||||||
andrographolide | 9675 | ||||||||
anifrolumab | 8258 | anifrolumab-fnia, MDX-1333, MEDI-546, Saphnelo® | |||||||
apafant | 1860 | WEB 2086 BS, WEB-2086 | |||||||
apilimod | 9859 | LAM-002A (apilimod dimesylate), LAM002A, STA 5326, STA-5326, STA5326 | |||||||
apratastat | 6482 | compound 5h [PMID: 16426848], TMI-05, TMI005 | |||||||
apremilast | 7372 | CC-10004, Otezla® | |||||||
APRIL | 5068 | A proliferation-inducing ligand, TALL2, TNF- and APOL-related leukocyte expressed ligand 2, TNF-related death ligand 1, TRDL-1, ZTNF2 | |||||||
AR-9281 | 13112 | AR9281, compound 14a [PMID: 21211973] | |||||||
arformoterol | 7479 | (-)-Formoterol, (R,R)-Formoterol, Brovana®, YM-08316 | |||||||
ARN19702 | 10120 | ARN-19702, compound 8 [PMID: 27404798] | |||||||
ARN726 | 9178 | ARN-726, compound 6 [PMID: 25874594] | |||||||
(R)-ARN2508 | 9000 | compound (-)-10r [PMID: 26774927], example 19 [WO2014023643] | |||||||
(S)-ARN2508 | 8999 | compound (+)-10r [PMID: 26774927], example 20 [WO2014023643] | |||||||
arpromidine | 1221 | ARP | |||||||
ARRY-371797 | 11095 | ARRY-797, ARRY371797, ARRY797, compound 7 [PMID: 19950901] | |||||||
ARRY-382 | 9108 | ARRY 382, ARRY382, c-Fms-IN-12, PF-07265804, PF07265804 | |||||||
ARRY-502 | 10179 | ARRY502, example 237, enantiomer 1 [WO2009158426A1] | |||||||
AS101 | 437 | ammonium tri-chloro(dioxoethylene-O,O'-)tellurate, AS 101, AS-101 | |||||||
AS-252424 | 10578 | AS252424, compound 26 [PMID: 16789742] | |||||||
asapiprant | 11951 | BGE-175, BGE175, example II-74 [US8153793B2], S-555739 | |||||||
asimadoline | 9279 | EMD 61 753, EMD 61753, EMD-61753 | |||||||
asivatrep | 9621 | Example 230 [US7858621], PAC-14028 | |||||||
ASP4058 | 9569 | ASP-4058 | |||||||
aspirin | 4139 | Acetophen®, acetylsalicylic acid, Aspirin® | |||||||
aspirin-triggered resolvin D1 | 6239 | AT-Resolvin D1, AT-RvD1 | |||||||
AT38 | 9020 | [3-(aminocarbonyl)furoxan-4-yl]methyl salicylate | |||||||
atacicept | 9517 | TACI-Fc, TACI-Ig | |||||||
atezolizumab | 7990 | MPDL3280A, Tecentriq® | |||||||
ATI-50001 | 12317 | ATI-501, ATI50001, ATI501, example 103 [WO2007070872A1] | |||||||
atibuclimab | 11326 | IC14 | |||||||
atracurium | 9537 | atracurium besilate, atracurium dibesylate, BW 33A, Tracrium® | |||||||
auranofin | 6306 | Ridaura®, SK&F-39162, SK-39162 | |||||||
avacopan | 9450 | CCX-168, CCX168, Tavneos® | |||||||
avadomide | 10522 | CC-122, CC122, Compound A [WO2014039960A1] | |||||||
avapritinib | 10368 | Ayvakit®, Ayvakyt®, BLU-285, BLU285 | |||||||
avdoralimab | 11345 | anti-hC5aR-32F3A6 GL, IPH-5401, NN-8210, NNC-0215-0384 | |||||||
AVE 0991 | 5579 | AVE-0991, AVE0991 | |||||||
avelumab | 8735 | Bavencio®, MSB-0010718C, MSB0010718C | |||||||
AX-024 | 11253 | AX-24, AX024 | |||||||
AZ13102909 | 9577 | AZ909 | |||||||
AZ2 | 10233 | ||||||||
AZ3451 | 9560 | ||||||||
AZ7188 | 9586 | ||||||||
AZ8838 | 9585 | ||||||||
azacitidine | 6796 | 5-AZAC, 5-azacytidine, ladakamycin, Onureg®, Onureg® (CC-486; oral azacitidine), U-18496, Vidaza® | |||||||
azapro-3 | 9221 | ||||||||
azatadine | 7119 | Optimine®, SCH-10649 | |||||||
azathioprine | 7120 | Azasan®, BW-57-322, Imuran®, Jayempi® | |||||||
AZD0284 | 11711 | AZD-0284, compound 20 [PMID: 34464130] | |||||||
AZD1236 | 7844 | AZD 1236, AZD-1236 | |||||||
AZD1678 | 9679 | AZD-1678, compound 49 [PMID: 28947948] | |||||||
AZD1981 | 7680 | AZD 1981, AZD-1981 | |||||||
AZD2098 | 9678 | AZD-2098, compound 47 [PMID: 28947948] | |||||||
AZD2423 | 7825 | AZD 2423, AZD-2423 | |||||||
AZD3458 | 9997 | AZD-3458, compound 15 [PMID: 29852070] | |||||||
AZD3965 | 10605 | AZD-3965 | |||||||
AZD5069 | 8948 | AZD-5069 | |||||||
AZD5423 | 13017 | AZD-5423, compound 1b [PMID: 28937774] | |||||||
AZD5672 | 7686 | AZD 5672, AZD-5672 | |||||||
AZD5718 | 10352 | compound 12 [PMID: 30869888] | |||||||
AZD6605 | 7823 | AZ 11920155, AZ-11920155, AZ11920155, AZD 6605, AZD-6605 | |||||||
AZD6703 | 7687 | AZ 12012199, AZ-12012199, AZ12012199, AZD 6703, AZD-6703 | |||||||
AZD7624 | 11714 | AZD-7624, Example 259 [WO2009001132] | |||||||
AZD8154 | 11204 | AZD-8154, Example 1 [WO2018055040A1] | |||||||
AZD8848 | 9256 | DSP-3025 | |||||||
AZD9056 | 7826 | AZD 9056, AZD-9056 | |||||||
AZD9567 | 9812 | AZD 9567, AZD-9567, compound 15 [PMID: 29424542], example 1 [WO2016046260A1] | |||||||
AZD9898 | 10479 | AZD-9898, example 62 [WO2016177845A1] | |||||||
azelaic acid | 7484 | Azelex®, Finacea®, ZK-62498 | |||||||
azithromycin | 6510 | ||||||||
AZ11657312 (salt free) | 7722 | ||||||||
B | Back to top | ||||||||
bafetinib | 7906 | INNO-406, Lyn-IN-1, NS-187 | |||||||
BAFF | 5069 | B cell-activating factor, CD257 antigen, dendritic cell-derived TNF-like molecule | |||||||
baicalin | 13076 | 7-D-glucuronic acid-5,6-dihydroxy-flavone, Baicalein 7-glucuronide, compound 15 [PMID: 37666112] | |||||||
balamapimod | 9925 | MKI-833, MKI833 | |||||||
bardoxolone | 2717 | CDDO, RTA-401 | |||||||
baricitinib | 7792 | INCB-028050, INCB028050, LY-3009104, LY3009104, Olumiant® | |||||||
basiliximab | 6879 | CHI-621, L04AC02, SDZ-CHI-621, Simulect® | |||||||
BAY 11-7082 | 5934 | (E)-3-tosylacrylonitrile, BAY-117082, BAY117082 | |||||||
BAY1830839 | 13101 | BAY-1830839, example 11 [WO2016083433A1] | |||||||
BAY-985 | 10597 | BAY985, compound 34 [PMID: 31859507] | |||||||
BAYu9773 | 3381 | BAY u9773, BAY-u 9773 | |||||||
BC-1215 | 12671 | BC 1215, BC1215 | |||||||
beclometasone | 7059 | beclomethasone, SCH-18020W | |||||||
beclometasone dipropionate | 5894 | beclomethasone dipropionate, Beconase®, Qnasl®, Vancenase® | |||||||
begelomab | 8691 | Begendina&rg; (proprietary name), BT 5/9, SAND 26 | |||||||
belantamab mafodotin | 11117 | belamaf, belantamab mafodotin-blmf, Blenrep®, GSK-2857916, GSK2857916 | |||||||
belatacept | 6892 | BMS-224818, LEA29Y, Nulojix® | |||||||
belimumab | 6887 | Benlysta®, hBlySmAb-1.1, LimphoStat-B, lymphostat-B | |||||||
belnacasan | 9035 | HMR3480, VX-765 | |||||||
belumosudil | 9558 | KD-025, KD025, Rezurock®, SLx 2119, SLx2119 | |||||||
bempegaldesleukin | 10659 | NKTR-214, NKTR214 | |||||||
benralizumab | 7674 | BIW-8405, Fasenra®, KHK4563, MEDI-563 | |||||||
bentamapimod | 9926 | AS-602801, AS602801, PGL-5001, PGL5001 | |||||||
benzodrocortisone | 9731 | compound 1 [WO2013071010], hydrocortisone 17-benzoate | |||||||
3beta-Hydroxy-20(29)-lupene | 9028 | Fagarasterol, Lupeol | |||||||
betamethasone | 7061 | SCH-4831 | |||||||
bexmarilimab | 12907 | Clevegen, FP-1305, FP1305 | |||||||
BI-1935 | 9717 | BI 1935, example 3 [WO2007067836] | |||||||
BI-1950 | 9719 | ||||||||
BI-2545 | 9791 | BI2545, compound 19 [PMID: 29259743] | |||||||
BI605906 | 9357 | 3-Amino-4-(1,1-difluoro- propyl)-6-(4-methanesulfonyl- piperidin-1-yl)-thieno[2,3- b]pyridine-2-carboxylic acid amide, compound 115 [US20070293533] | |||||||
BI 653048 | 9715 | (R)-39, BI 653048 BS H3PO4, BI-653048, BI653048 | |||||||
BI 665915 | 9716 | BI-665915, compound 69 [PMID: 25671290] | |||||||
BI-6901 | 9714 | BI 6901, BI 6901, BI6901, eut-22 | |||||||
bifikafusp alfa | 9756 | Darleukin, L19-IL2, L19IL2 | |||||||
bihelical apoA-I mimetic peptide 5A | 9183 | 5A peptide | |||||||
BIIB068 | 11178 | BIIB-068, compound 1 [PMID: 32696648] | |||||||
bimekizumab | 9411 | bimekizumab-bkzx, Bimzelx®, CA028_0496, CDP4940, gL7gH9, UCB-4940, UCB4940, Zu-G1 | |||||||
bimosiamose | 9049 | compound 15e [PMID: 9544210], TBC 1269, TBC-1269, TBC1269 | |||||||
bindarit | 11124 | AF-2838, AF2838 | |||||||
BIO-7488 | 13341 | BIO7488 | |||||||
BIO-8169 | 13355 | BIO8169, compound 2 [PMID: 38695469] | |||||||
BIRT 377 | 9720 | BIRT-377 | |||||||
blinatumomab | 7384 | Blincyto®, bscCD19xCD3, MEDI-538, MT-103, MT103 | |||||||
blisibimod | 9518 | A-623, AGP3 peptibody, AMG 623, Fc-Agp-3 | |||||||
BML-281 | 9664 | compound 3 [PMID: 18642892] | |||||||
BMS-1001 | 10191 | BMS1001, Example 1001 [WO2015160641A2] | |||||||
BMS-1166 | 9608 | compound 2c [PMID: 28613862], Example 1166 [WO2015160641A2] | |||||||
BMS-202 | 9607 | compound 1c [PMID: 28613862], PD1-PDL1 inhibitor 2 | |||||||
BMS-345541 | 5669 | BMS 345541, BMS345541 | |||||||
BMS-509744 | 9994 | BMS 509744, BMS509744, compound 3 [PMID:16682193] | |||||||
BMS-561392 | 6509 | BMS 561392, BMS561392, DPC-333 | |||||||
BMS-582949 | 7838 | BMS 582949, BMS582949, PS 540446, PS-540446, PS540446 | |||||||
BMS-681 | 9430 | compound 13d [PMID: 25893046] | |||||||
BMS-817399 | 9497 | compound 29 [PMID: 25101488] | |||||||
BMS-986142 | 9857 | BMS986142, compound 14f [PMID: 27583770] | |||||||
BMS-986166 | 11493 | BMS986166, compound 14a [PMID: 30785748] | |||||||
BMS-986235 | 11024 | BMS986235, compound 13c [PMID: 32407089], LAR-1219, LAR1219 | |||||||
BMS-986260 | 10662 | BMS986260, compound 10 [Velaparthi et al., 2020], Example 32' [WO2016140884A1] | |||||||
BMS-986104 derivative 12 | 11494 | compound 12 [PMID: 33492963] | |||||||
BMS-986104 derivative 24 | 11495 | compound 24 [PMID: 33492963] | |||||||
bortezomib | 6391 | peptide boronate, PS-341, Velcade® | |||||||
bosutinib | 5710 | Bosulif®, SK 606, SK-606, SKI 606 | |||||||
branebrutinib | 9869 | BMS-986195, BMS986195, Example 223 [US20160115126A1] | |||||||
brazikumab | 9293 | AMG 139, AMG-139, MEDI2070 | |||||||
brensocatib | 9412 | AZD7986, compound 30, INS 1007, INS1007 | |||||||
brentuximab vedotin | 6772 | Adcetris®, anti-CD30 ADC SGN-35, SGN 35 | |||||||
brepocitinib | 10459 | compound 23 [PMID: 30113844], PF-06700841, PF06700841 | |||||||
briakinumab | 9213 | ABT-874, J-695, J695, Ozespa | |||||||
brimapitide | 9101 | AM-111, D-JNKI-1, XG-102 | |||||||
brimonidine (UK14304) | 520 | Alphagan®, Lumify®, Mirvaso®, UK14,304, UK14304 | |||||||
BRL-15572 | 10 | BRL 15572, BRL-15,572, BRL15572 | |||||||
brodalumab | 7540 | AMG-827, AMG827, Kyntheum®, Lumicef®, Siliq® | |||||||
bromfenac | 7131 | AHR-10282B, Bromday®, Prolensa®, Xibrom® | |||||||
BsAb (CD89-CD20) | 9833 | ||||||||
BT7480 | 12060 | BCY11863, BT-7480 | |||||||
BTP2 | 2438 | YM-58483 | |||||||
budesonide | 7434 | Entocort®, Eohilia® (budesonide oral suspension), Jorveza®, Pulmicort®, S-1320, Uceris® | |||||||
butyric acid | 1059 | butanoic acid, butyrate, C4 | |||||||
BX 471 | 767 | BX-471, BX-741 | |||||||
BX-795 | 8006 | BX 795, BX795 | |||||||
C | Back to top | ||||||||
C108297 | 9180 | Compound 52 [PMID:18226897] | |||||||
C1-27 | 10719 | GSTO1-IN-1 | |||||||
C-176 | 13136 | C-176 STING inhibitor | |||||||
C391 | 9570 | compound 5 [PMID: 27994760] | |||||||
C646 | 7004 | ||||||||
C5a | 573 | C5a anaphylatoxin, complement component C5a, human complement protein | |||||||
cabiralizumab | 9107 | BMS-986227, FPA-008, FPA008 | |||||||
cadonilimab | 12966 | AK-104, AK104 | |||||||
camoteskimab | 13187 | AEVI 007, AEVI-007, AVTX 007, AVTX-007, CERC 007, CERC-007, MEDI 2338 | |||||||
camrelizumab | 9758 | INCSHR1210, SHR-1210 | |||||||
canakinumab | 6773 | ACZ 885, ACZ885, Ilaris® | |||||||
canertinib | 5675 | CI 1033, CI-1033, PD 183805 dihydrochloride | |||||||
carotegrast | 10511 | HCA2969 | |||||||
carotegrast methyl | 10510 | AJM-300, AJM300, Carogra® | |||||||
carprofen | 7141 | Ro-205720000 | |||||||
CBS-3595 | 9610 | ||||||||
CC-885 | 9224 | ||||||||
CCL1 | 812 | I309, TCA-3 | |||||||
CCL1 | 4404 | ||||||||
CCL11 | 769 | eotaxin | |||||||
CCL11 | 4416 | ||||||||
CCL11 | 787 | murine eotaxin | |||||||
CCL12 | 4435 | ||||||||
CCL13 | 770 | monocyte chemotactic protein-4 | |||||||
CCL14 | 753 | CCL14a, CKβ1, haemofiltrate CC chemokine 1 (HCC-1), HCC-1(1-74) | |||||||
CCL15 | 754 | Lkn-1 [Leukotactin-1], macrophage inflammatory protein-1δ, MIP-1δ | |||||||
CCL16 | 1272 | ||||||||
CCL17 | 797 | TARC, thymus- and activation-regulated chemokine | |||||||
CCL18 | 4382 | macrophage inflammatory protein 4, small-inducible cytokine A18 | |||||||
CCL19 | 810 | β-chemokine exodus-3, ck β-11, ckβ11, MIP-3β | |||||||
CCL19 | 4417 | ||||||||
CCL2 | 4406 | ||||||||
CCL2 | 771 | ||||||||
CCL2 | 4407 | ||||||||
CCL20 | 4418 | ||||||||
CCL20 | 808 | LARC, liver and activation-regulated chemokine, macrophage inflammatory protein-3α, MIP-3α | |||||||
CCL20 | 4419 | ||||||||
CCL21 | 811 | ckβ9, TCA-4 | |||||||
CCL22 | 4420 | ||||||||
CCL22 | 798 | dc/β-ck, macrophage-derived chemokine, STCP1 | |||||||
CCL23 | 755 | ckβ8-1, myeloid progenitor inhibitor factor-1 | |||||||
CCL24 | 4421 | ||||||||
CCL24 | 775 | eotaxin-2 | |||||||
CCL25 | 4422 | ||||||||
CCL25 | 817 | ||||||||
CCL26 | 776 | MIP-4α, PTEC | |||||||
CCL27 | 4462 | ||||||||
CCL27 | 3646 | ||||||||
CCL28 | 4463 | ||||||||
CCL28 | 3649 | ||||||||
CCL3 | 4408 | ||||||||
CCL3 | 756 | macrophage inflammatory protein-1α, MIP-1α | |||||||
CCL3 | 4409 | ||||||||
CCL4 | 4411 |